DMAC DiaMedica Therapeutics Inc.
$6.47▲ +0.00%
Healthcare
Other
After hours
$6.47▲ +0.00%
Sep 11, 7:30 PM ET
Volume 123.6K
Avg Volume (10D) 146.2K
Key Metrics & Fundamentals
Market Cap
$348.90M
P/E Ratio
–
Div Yield
–%
52W Range
5.25 - 10.42
% vs 50 MA
-5.75%
% vs 200 MA
-10.01%
RSI-14
45.6
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.51
Free Cash Flow
-$8.12M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$10.49M
COGS
–
Operating Exp
$10.50M
Operating Income
-$10.50M
EBIT
-$10.50M
Pretax Income
-$10.13M
Net Income
-$10.14M
EPS (Diluted)
-0.19
Price & Volume History
Loading chart…
Recent News
DiaMedica Therapeutics to Participate in Upcoming September Investor Conferences
Business Wire · Sep 2, 2026 12:30 PM
Wall Street Analysts Think DiaMedica Therapeutics (DMAC) Could Surge 129.97%: Read This Before Placing a Bet
Zacks · Aug 26, 2026 1:55 PM
DiaMedica (DMAC) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 18, 2026 1:29 AM
All You Need to Know About DiaMedica Therapeutics (DMAC) Rating Upgrade to Buy
Zacks · Aug 13, 2026 4:00 PM
DiaMedica Therapeutics Inc (DMAC) (Q2 2026) Earnings Call Highlights: Promising Preeclampsia ...
GuruFocus.com · Aug 11, 2026 7:01 PM
DiaMedica Therapeutics Inc. Q2 2026 Earnings Call Summary
Moby · Aug 11, 2026 5:26 PM
DiaMedica Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 11, 2026 1:04 PM
DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
Business Wire · Aug 10, 2026 8:30 PM
DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026
Business Wire · Aug 4, 2026 8:30 PM
DiaMedica Therapeutics (DMAC): BioTech with Breakthrough Potential
Insider Monkey · Aug 3, 2026 3:09 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See DMAC's money flow as a full page
Social Sentiment
No Reddit posts found for DMAC.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.